(Q39607736)

13 September 2017

title

Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer (English)

1 reference

13 September 2017

1 reference

Verónica Tapia

1

1 reference

13 September 2017

Fernando Gabler

2

1 reference

13 September 2017

Marcela Muñoz

3

1 reference

13 September 2017

Roberto Yazigi

4

1 reference

13 September 2017

Alfonso Paredes

5

1 reference

13 September 2017

Alberto Selman

6

1 reference

13 September 2017

Margarita Vega

7

1 reference

13 September 2017

Carmen Romero

8

1 reference

13 September 2017

language of work or name

English

0 references

publication date

14 January 2011

1 reference

13 September 2017

1 reference

13 September 2017

volume

121

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

13-23

1 reference

Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

Benign epithelial ovarian tumours-cancer precursors or markers for ovarian cancer risk?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

Expression of nerve growth factor receptors is correlated with progression and prognosis of human pancreatic cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

Nerve growth factor control of neuronal expression of angiogenetic and vasoactive factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

Effects of nerve growth factor (NGF) on blood vessels area and expression of the angiogenic factors VEGF and TGFbeta1 in the rat ovary

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

Nerve growth factor induces vascular endothelial growth factor expression in granulosa cells via a trkA receptor/mitogen-activated protein kinase-extracellularly regulated kinase 2-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

The activated nerve growth factor receptor p-TrkA is selectively expressed in advanced-stage ovarian carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

Nerve growth factor-dependent activation of trkA receptors in the human ovary results in synthesis of follicle-stimulating hormone receptors and estrogen secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

In vitro model of angiogenesis using a human endothelium‐derived permanent cell line: Contributions of induced gene expression, G‐proteins, and integrins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

TrkA overexpression enhances growth and metastasis of breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

Angiogenesis in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

Vascular endothelial growth factor in ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

Mechanisms of normal and tumor-derived angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2010.12.341

10.1016/J.YGYNO.2010.12.341

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference